Hepatic steatosis is a predictor of poor response to interferon alpha-2b and ribavirin combination therapy in Japanese patients with chronic hepatitis C. (Q50576824)
Jump to navigation
Jump to search
scientific article published on 13 March 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Hepatic steatosis is a predictor of poor response to interferon alpha-2b and ribavirin combination therapy in Japanese patients with chronic hepatitis C. |
scientific article published on 13 March 2006 |
Statements
1 reference
Hepatic steatosis is a predictor of poor response to interferon alpha-2b and ribavirin combination therapy in Japanese patients with chronic hepatitis C. (English)
1 reference
Reiko Yaginuma
1 reference
Kenichi Ikejima
1 reference
Kyoko Okumura
1 reference
Kazuyoshi Kon
1 reference
Satoko Suzuki
1 reference
Yoshiyuki Takei
1 reference
Nobuhiro Sato
1 reference
13 March 2006
1 reference
1 reference
35
1 reference
1
1 reference
19-25
1 reference
Identifiers
1 reference